Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group
- 1 January 2010
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 18 (1), 415-425
- https://doi.org/10.1016/j.bmc.2009.10.042
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Identification and Characterization of Small Molecule Inhibitors of a Class I Histone Deacetylase from Plasmodium falciparumJournal of Medicinal Chemistry, 2009
- Non-Peptide Macrocyclic Histone Deacetylase InhibitorsJournal of Medicinal Chemistry, 2008
- Antimalarial Activity of Phenylthiazolyl-Bearing Hydroxamate-Based Histone Deacetylase InhibitorsAntimicrobial Agents and Chemotherapy, 2008
- Potent Antimalarial Activity of Histone Deacetylase Inhibitor AnaloguesAntimicrobial Agents and Chemotherapy, 2008
- Discovery and development of SAHA as an anticancer agentOncogene, 2007
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Histone Deacetylase Enzymes as Potential Drug Targets in Cancer and Parasitic DiseasesJournal of Biomedicine and Biotechnology, 2006
- The Genome of the Kinetoplastid Parasite, Leishmania majorScience, 2005
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- On Cyclic Intermediates in Substitution Reactions. III. The Alkaline Hydrolysis of ε-Bromocaproic and ζ-Bromoenanthic AcidsJournal of the American Chemical Society, 1953